Immunome, which has developed a way to clone monoclonal human antibodies that can be used to help develop more effective cancer drugs and with potential applications for rare diseases, has signed its first research and development partnership with a Big Pharma company. The Wynnewood, Pennsylvania company’s approach differs from its competitors, says Timothy Pelura, the […]
A Pennsylvania biotechnology company is raising $1.5 million to advance its human antibody cloning technology that it believes has broad applications for the treatment of unmet medical needs such as Alzheimer’s disease, cancer, infectious diseases and bioterror attacks. In its latest financing round, begun Jan. 4, Immunome has raised $145,000. Dr. Scott K. Dessain, […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.